Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$18.80 +0.56 (+3.10%)
At close: Sep 30, 2026 · 4:00 PM EDT

Syndax Pharmaceuticals (SNDX) Total Non-Current Liabilities (2015 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Total Non-Current Liabilities of $588.88 million in Q2 2026, up 80.8% from $325.74 million a year earlier and up 70.8% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Total Non-Current Liabilities of $344.96 million, up 3.5% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of 63.5% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $333.14 million in FY2024, $588,000 in FY2023 (-18.6%), $722,000 in FY2022 (-96.5%) and $20.61 million in FY2021 (-30.3%).
  • The Q2 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2015.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for three consecutive quarters, with an average decline of 2.8% over the last four quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 80.8% in Q2 2026, against a decline of 99.8% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $344.87 million (Q1 2026), $344.96 million (Q4 2025) and $322.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 Syndax Pharmaceuticals 1.63 Bn -103.87 Mn 69.58 Mn 588.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 588.88 Mn
Mar 31, 2026 344.87 Mn
Dec 31, 2025 344.96 Mn
Sep 30, 2025 322.18 Mn
Jun 30, 2025 325.74 Mn
Mar 31, 2025 331.10 Mn
Dec 31, 2024 333.14 Mn
Sep 30, 2024 2,000.00
Jun 30, 2024 137,000.00
Mar 31, 2024 334,000.00
Dec 31, 2023 588,000.00
Sep 30, 2023 864,000.00
Jun 30, 2023 1.13 Mn
Mar 31, 2023 600,000.00
Dec 31, 2022 722,000.00
Sep 30, 2022 782,000.00
Jun 30, 2022 13.57 Mn
Mar 31, 2022 17.12 Mn
Dec 31, 2021 20.61 Mn
Sep 30, 2021 11.79 Mn
API Access

Syndax Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SNDX&period=max&api_key=YOUR_API_KEY